Open AccessUpper gastrointestinal bleeding in patients with stable coronary artery disease (registry of antithrombotic therapy “REGATТA” results)
Author(s) -
О. О. Шахматова,
А. Л. Комаров,
V Korobkova,
E. B. Yarovaya,
M. V. Andreevskaya,
А. Г. Шулешова,
Е. П. Панченко
Publication year - 2020
Publication title -
terapevtičeskij arhiv
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.181
H-Index - 14
eISSN - 2309-5342
pISSN - 0040-3660
DOI - 10.26442/00403660.2020.09.000699
Subject(s) - medicine , esophagogastroduodenoscopy , coronary artery disease , concomitant , upper gastrointestinal bleeding , clopidogrel , antithrombotic , surgery , gastrointestinal bleeding , gastroenterology , myocardial infarction , endoscopy
Upper gastrointestinal (UGI) bleeding is a common complication of antiplatelet therapy. Data from real clinical practice that characterize the range of risk factors for UGI bleeding, prophylactic proton pump inhibitors (PPIs) therapy, bleeding frequency and their long-term effects in patients with stable coronary artery disease (CAD) are limited.